儿童脑肿瘤质子束治疗后影像学改变的风险建模
该回顾性匹配队列研究纳入93例儿童脑肿瘤质子束治疗患者,分析治疗后影像学改变(IC)与临床、放射生物学及剂量学因素的关系。体素水平分析发现剂量D与质子剂量平均LETd乘积(σ=6 mm,排除低于5 Gy(RBE)体素)是IC概率增加的关键预测因子;患者水平分析显示健康脑接受>20 Gy(RBE)体积内中位剂量(D50%)最显著。
要点
- 体素水平关键预测因子为D·LETdproton乘积(σ=6 mm,排除<5 Gy(RBE)体素)。
- 患者水平最显著因子为健康脑>20 Gy(RBE)体积内中位剂量D50%。
- 15例出现治疗后影像学改变,位于脑干、室周区及其他脑区。
核心结论
- 识别的体素和患者水平单因素风险因子为预测儿童中枢神经系统肿瘤质子束治疗后影像学改变提供基础。
研究设计与样本
- 回顾性分析93例儿童质子束治疗患者的3:1匹配对队列,随访MRI数据至治疗后14个月。
主要发现
- 共15例出现治疗后影像学改变,分布于脑干、室周区及其他脑区。
- 体素水平关键预测因子为D·LETdproton乘积(σ=6 mm,排除低于5 Gy(RBE)体素)。
- 患者水平最显著因子为健康脑接受>20 Gy(RBE)体积内的中位剂量D50%。
关键数值与推荐
- 体素水平分析排除低于5 Gy(RBE)的体素。
- 高斯滤波标准差σ为6 mm用于处理空间不确定性。
临床怎么用
- 可基于D·LETdproton乘积和健康脑>20 Gy(RBE)体积内D50%优化治疗计划以降低影像学改变风险。
局限性
- 回顾性研究设计,样本量93例,随访MRI数据仅至治疗后14个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: In childhood brain tumors, minimizing long-term side effects of cancer therapy is a critical objective. Radiation-related imaging changes (ICs), indicative of potential radionecrosis, remain an area of active investigation in proton beam therapy (PBT). This study aimed to identify and correlate post-therapeutic ICs and radio-biological and dosimetric factors, including linear energy transfer (LET) and variable relative biological effectiveness (RBE), as well as clinical factors. MATERIALS AND METHODS: A 3:1 matched-pair cohort of 93 pediatric PBT patients from a register study was retrospectively analyzed. The cohort comprised various brain tumor entities, with follow-up MRI data available up to 14 months post-treatment. Potential clinical risk factors for therapy-induced ICs in pediatric brains were analyzed using logistic regression at both patient and voxel levels. Dosimetric parameters were evaluated for the entire brain, periventricular region (PVR), and brainstem. RESULTS: A total of 15 cases with post-therapeutic ICs from various childhood tumor entities were identified and localized in the brainstem, the PVR, and other brain regions. At the voxel level, the key predictor linked to increased IC probability was the product of dose D and proton dose-averaged LETd (D · LETdproton)σ=6 mm, excluding voxels below 5 Gy (RBE). The Gaussian filtering with a standard deviation σ of 6 mm served as a practical approach to account for spatial uncertainties. At the patient level, the median dose (D50%) within the volume of the healthy brain receiving more than 20 Gy (RBE) was most significant. CONCLUSION: The identified univariate voxel- and patient-level risk factors provide a foundation for predicting post-therapeutic ICs in pediatric CNS tumor patients treated with PBT. Our findings contribute to refining risk prediction models and optimizing treatment planning strategies, ultimately aiming to minimize long-term radiation-induced effects in pediatric brain tumor patients.
引用
- Heinzelmann F, Peters S, Quenzer A, et al. Risk modeling of imaging changes after proton beam therapy for childhood brain tumors. Radiother Oncol. 2025. PMID: 41192767. doi:10.1016/j.radonc.2025.111261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。